FCC ID 2AA923614-04
In Touch Blood Glucose Monitoring System
by Livongo Health, Inc.
Grantee Code: 2AA92 Product Code: 361404
Latest application date: 2013-12-15
FCC ID Device Details
Operating Frequencies
| Frequency Range | Application Purpose | Final Action Date |
|---|---|---|
| 824.2-848.8 MHz | Original Equipment | 2013-12-15 |
Exhibits
| Document | Type | Available | File |
|---|---|---|---|
| Owners manual | Users Manual | 2014-06-13 | PDF 1.3 MB |
| Internal photos | Internal Photos | 2014-06-13 | PDF 342.7 KB |
| External photos | External Photos | 2014-06-13 | PDF 1.3 MB |
| Label | ID Label/Location Info | 2013-12-15 | PDF 317.9 KB |
| Label location | ID Label/Location Info | 2013-12-15 | PDF 653.5 KB |
| Test setup | Test Setup Photos | 2014-06-13 | PDF 334.3 KB |
| Test report | Test Report | 2013-12-15 | PDF 998.2 KB |
| CoC letter | Attestation Statements | 2013-12-15 | PDF 23.1 KB |
| Permission letter | Attestation Statements | 2013-12-15 | PDF 823.3 KB |
| Reference letter | Attestation Statements | 2013-12-15 | PDF 92.5 KB |
| Authorisation letter | Cover Letter(s) | 2013-12-15 | PDF 36.4 KB |
| Confidentiality letter | Cover Letter(s) | 2013-12-15 | PDF 35.1 KB |
| SAR justification | RF Exposure Info | 2013-12-15 | PDF 115.4 KB |
Application Information
| Application ID | /hOApqJWm6yfWDRS9YoVdQ== |
|---|---|
| Final Action Date | 2013-12-15 |
| Application Purpose | Original Equipment |
| Applicant FRN | 0023086168 |
| Model | 3614-04 |
| Frequency Range | 824.2-848.8 MHz |
| Equipment Class | PCB - PCS Licensed Transmitter |
| Device Description | In Touch Blood Glucose Monitoring System |
| Responsible Party | Kimon Jerry Angelides, Chief Executive Officer, kangelides@eoshealth.com |
| Test Firm | John Newell, UL VS Ltd, john.newell@ul.com |
| TCB Email | Tom.Twynam@babt.com |
| TCB Scope | B1: Commercial mobile radio services equipment in the following 47 CFR Parts 20, 22 (cellular), 24,25 & 27 |
| Short-Term Confidentiality | Yes |
| Short-Term Confidentiality Date | 06/13/2014 |
| Long-Term Confidentiality | Yes |
| Grant Deferral | No |
| Modular Equipment | Does not apply |
| Composite Device | No |
| Composite Part | No |
| Cognitive Radio | No |
| Authorization Waiver | No |
| Authorization Waiver Approved | No |
| Section 5301 Certification | Yes |
| Related OET Knowledge DataBase Inquiry | No |
| Grant Comments | Power listed is conducted. Device must operate with a maximum duty factor not exceeding that described in this filing. The duty factor must be implemented in factory firmware. The antenna(s) used for this transmitter must not be co-located or operating in conjunction with any other antenna or transmitter except in accordance with FCC multi-transmitter evaluation procedures. This device contains functions that are not operational in U.S. Territories. This filing is only applicable for U.S. operations. |
Applications
| Application ID | Date | Purpose |
|---|---|---|
| /hOApqJWm6yfWDRS9YoVdQ== | 2013-12-15 | Original Equipment |
Equipment Authorization
Grants
TCB Grant - Application /hOApqJWm6yfWDRS9YoVdQ==
| TCB | GRANT OF EQUIPMENT AUTHORIZATION |
TCB |
| Certification | ||
| Issued Under the Authority of the | ||
| Federal Communications Commission | ||
| By: |
|
TUV SUD BABT Octagon House, Concorde Way, Segensworth North, Fareham, PO15 5RL United Kingdom |
Date of Grant: 12/15/2013 Application Dated: 12/15/2013 |
| EosHealth, Inc. |
| 2800 Post Oak Boulevard |
| 41st Floor |
| Houston, TX 77057 |
| Attention: Kimon Angelides , Chief Executive Officer |
| NOT TRANSFERABLE |
| EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below. |
| FCC IDENTIFIER: | 2AA923614-04 |
| Name of Grantee: | EosHealth, Inc. |
| Equipment Class: | PCS Licensed Transmitter |
| Notes: | In Touch Blood Glucose Monitoring System |
| Grant Notes | FCC Rule Parts | Frequency Range (MHZ) | Output Watts | Frequency Tolerance | Emission Designator |
| 22H | 824.2 - 848.8 | 1.74 | 15.0 Hz | 300KGXW | |
| 24E | 1850.2 - 1909.8 | 1.0 | 15.0 Hz | 300KGXW |
| Power listed is conducted. Device must operate with a maximum duty factor not exceeding that described in this filing. The duty factor must be implemented in factory firmware. The antenna(s) used for this transmitter must not be co-located or operating in conjunction with any other antenna or transmitter except in accordance with FCC multi-transmitter evaluation procedures. This device contains functions that are not operational in U.S. Territories. This filing is only applicable for U.S. operations. |
EAS Grant - Application /hOApqJWm6yfWDRS9YoVdQ==
| COPY |
FEDERAL COMMUNICATIONS COMMISSION WASHINGTON, D.C. 20554 GRANT OF EQUIPMENT AUTHORIZATION |
COPY |
| Certification |
|
EosHealth, Inc. 2800 Post Oak Boulevard 41st Floor Houston, TX 77057 United States |
Date of Grant: 12/15/2013 Application Dated: 12/15/2013 |
| Attention: Kimon Angelides , Chief Executive Officer |
| NOT TRANSFERABLE |
| EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below. |
| FCC IDENTIFIER: | 2AA923614-04 |
| Name of Grantee: | EosHealth, Inc. |
| Equipment Class: | PCS Licensed Transmitter |
| Notes: | In Touch Blood Glucose Monitoring System |
| Modular Type: | Does not apply |
| Grant Notes | FCC Rule Parts | Frequency Range (MHZ) | Output Watts | Frequency Tolerance | Emission Designator |
| 22H | 824.2 - 848.8 | 1.74 | 15.0 Hz | 300KGXW | |
| 24E | 1850.2 - 1909.8 | 1.0 | 15.0 Hz | 300KGXW |
| Power listed is conducted. Device must operate with a maximum duty factor not exceeding that described in this filing. The duty factor must be implemented in factory firmware. The antenna(s) used for this transmitter must not be co-located or operating in conjunction with any other antenna or transmitter except in accordance with FCC multi-transmitter evaluation procedures. This device contains functions that are not operational in U.S. Territories. This filing is only applicable for U.S. operations. |
| Mail To: |